Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference12 articles.
1. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction;Mukamal;Diabetes Care,2001
2. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the valsartan in acute myocardial infarction (VALIANT) trial;Aguilar;Circulation,2004
3. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the global registry of acute coronary events (GRACE);Goodman;Am Heart J,2006
4. Milrinone for the treatment of acute heart failure after acute myocardial infarction: a systematic review and meta-analysis;Tang;Basic Clin Pharmacol Toxicol,2015
5. Heart failure with preserved ejection fraction: from mechanisms to therapies;Lam;Eur Heart J,2018
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Improving cardiac function of angiotensin receptor/ neprilysin inhibitor in patients with acute myocardial infarction: a systematic review and meta-analysis;CARDIOVASC J AFR;2023
2. PROTECTIVE EFFECTS OF ULTRASOUND-BASED PREOPERATIVE EXOGENOUS SACUBITRIL/VALSARTAN ON THE HEART AND KIDNEY OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION;FARMACIA;2023-08-31
3. Effect of Angiotensin Receptor-Neprilysin Inhibitor on Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction in Kuwait;Annals of Clinical Cardiology;2023-07
4. Effects of sacubitril-valsartan on heart failure patients with mid-range ejection fractions: A systematic review and meta-analysis;Frontiers in Pharmacology;2022-10-24
5. A systematic review and meta-analysis of sacubitril-valsartan in the treatment of ventricular remodeling in patients with heart failure after acute myocardial infarction;Frontiers in Cardiovascular Medicine;2022-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3